(Q35163753)

6 August 2017

1 reference

title

Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury (English)

1 reference

6 August 2017

0 references

Lala PK

1

1 reference

PubMed ID

12828917

6 August 2017

Chakraborty C

series ordinal

2

1 reference

PubMed ID

12828917

6 August 2017

language of work or name

1 reference

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

24

1 reference

6 August 2017

575-587

1 reference

6 August 2017

6

1 reference

Placental apoptosis in preeclampsia

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Significant decrease of maternal serum serotonin levels in singleton pregnancies complicated by the HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Prospective function of placental leptin at maternal-fetal interface

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The effects of vascular endothelial growth factor on endothelial cells: A potential role in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Activin Is a Local Regulator of Human Cytotrophoblast Cell Differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3)

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Trophoblast invasion of spiral arteries: a novel in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Regulation of human trophoblast migration and invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

A longitudinal study of biochemical variables in women at risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Circulating levels of immunoreactive cytokines in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma interleukin-12 is elevated in patients with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Primary, secondary, and tertiary prevention of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Comparison of plasma concentrations of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) in normal and preeclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Paternal and maternal components of the predisposition to preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Adhesive and degradative properties of human placental cytotrophoblast cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Implication of apolipoprotein E and the L-arginine-nitric oxide system in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Serum laminin levels in normal pregnancy and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Villous culture of first trimester human placenta--model to study extravillous trophoblast (EVT) differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Establishment and characterization of first trimester human trophoblast cells with extended lifespan

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Mechanism of control of trophoblast invasion in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Placental proteins 12 and 14 in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast alpha5beta1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

ED(27) trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

[Measuring the concentration of various plasma and placenta extract proteolytic and vascular factors in pregnant patients with HELLP syndrome, pre-/eclampsia and highly pathologic Doppler flow values]

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Vascular endothelial growth factor is increased in patients with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Contemporary concepts of the pathogenesis and management of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

TGFB-responsive human trophoblast-derived cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Pre-eclampsia and expression of heparin-binding EGF-like growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Fetal and maternal contributions to risk of pre-eclampsia: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Epidermal growth factor in maternal urine--a predictor of intrauterine growth restriction?

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Nitric oxide dysfunction in the pathophysiology of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The human placental bed revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Localization of transforming growth factor alpha in the human placenta and decidua: role in trophoblast growth

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Localization of amphiregulin in the human placenta and decidua throughout gestation: role in trophoblast growth

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Hyperuricemia and xanthine oxidase in preeclampsia, revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Potential role of endothelin-1 in normal and hypertensive pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Hyperhomocysteinaemia and human reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Preeclamptic serum enhances endothelin-converting enzyme expression in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Methylenetetrahydrofolate reductase 677 C --> T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Preeclampsia: an excessive maternal inflammatory response to pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Endothelial dysfunction in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Is oxidative stress the link in the two-stage model of pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Recent Insights into the pathogenesis of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Pre-eclampsia: more than pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

The origin of endothelin-1 in patients with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Insulin-like growth factor binding protein-1 in female reproductive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

An instructive case of abdominal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Transforming growth factor beta expression in human placenta and placental bed during early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Free leptin is increased in normal pregnancy and further increased in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Preeclampsia is associated with reduced serum levels of placenta growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Transforming growth factor-beta1 regulates hepatocyte growth factor-induced trophoblast motility and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Nitric oxide/endothelin-1 in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

1 reference

7 January 2021

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Reconstitution of Smad3 restores TGF-beta response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: growth pattern, markers, and hormone production

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4004%2803%2900063-8

7 January 2021

10.1016/S0143-4004(03)00063-8

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12828917